Indian stem cell bank LifeCell International Pvt. Ltd on Tuesday announced fundraise of ₹225 crore from a healthcare investment firm OrbiMed Asia Partners IV.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in